684233-26-9

Upstream product

• 684233-25-8 C₅₃H₆₄N₈O₁₁ 
• 684233-23-6 (S)-2-[(S)-2-{3-[(S)-1-((R)-2-tert-Butoxycarbonylamino-propionylamino)-ethyl]-[1,2,4]triazol-4-yl}-3-(4-methoxy-phenyl)-propionylamino]-propionic acid methyl ester 
• 684233-24-7 (S)-2-[(S)-2-{3-[(S)-1-((R)-2-tert-Butoxycarbonylamino-propionylamino)-ethyl]-[1,2,4]triazol-4-yl}-3-(4-methoxy-phenyl)-propionylamino]-propionic acid 
• 684233-22-5 (S)-2-[(S)-2-[3-((S)-1-tert-Butoxycarbonylamino-ethyl)-[1,2,4]triazol-4-yl]-3-(4-methoxy-phenyl)-propionylamino]-propionic acid methyl ester 
• 304466-90-8 (9S,12S)-12-(tert-Butoxycarbonyl-methyl-amino)-4-methoxy-10-methyl-11-oxo-2-oxa-10-aza-tricyclo[12.2.2.1^3,7]nonadeca-1⁽¹⁷⁾,3⁽¹⁹⁾,4,6,14⁽¹⁸⁾,15-hexaene-9-carboxylic acid benzyl ester 
• 3744-87-4 Boc-(R)-Ala 

Downstream Products

• 684233-27-0 C₄₁H₅₀N₈O₉ 

Relevant academic research and scientific papers

Semisynthesis of an analogue of antitumor bicyclic hexapeptide RA-VII by fixing the Ala-2/Tyr-3 bond to cis by incorporating a triazole cis-amide bond surrogate

We prepared an analogue of an antitumor bicyclic hexapeptide RA-VII whose amide configuration between residues 2 and 3 was fixed to cis by incorporating a triazole cis-amide bond surrogate. This analogue was shown, by NMR studies, to take almost the same